AMBULATORY BLOOD PRESSURE MONITORS MARKET ANALYSIS

Global ambulatory blood pressure monitors market size is expected to reach US$ 2,934.6 Mn by 2030, from US$ 1,663.6 Mn in 2023, exhibiting compound annual growth rate (CAGR) of 8.4% during the forecast period.

Analyst View: Global ambulatory blood pressure monitors market is expected to witness significant growth opportunities driven by the rising prevalence of hypertension globally. Increasing awareness about the benefits of home monitoring of blood pressure and technological advances enabling miniaturization of ambulatory blood pressure monitors (ABPM) devices are fueling adoption. However, data privacy concerns related to the storage and sharing of patients' health data may hinder the market expansion to some extent.

The ambulatory blood pressure monitors market is segmented based on product type, end user, and region. Based on technology, the market is segmented into Wrist Monitors, and Arm Monitors. Wrist Monitors is dominating the market owing to increasing launches of Wrist ambulatory blood pressure monitors

Global Ambulatory Blood Pressure Monitors Market Regional Insights:

• North America is estimated to be the largest market for ambulatory blood pressure monitors during the forecast period, which accounted for over 3% of the market share in 2023. The market growth in North America is due to the increasing prevalence of hypertension and rising awareness about advanced ambulatory monitors. Growing geriatric population who are more susceptible to hypertension will further propel demand
• Europe is expected to be the second-largest market for ambulatory blood pressure monitors, which accounted for over 5% of the market share in 2023. The market growth in Europe is due to the rising geriatric population who are more prone to develop hypertension, will further propel the demand for ambulatory blood pressure monitors in Europe. Growing awareness about advantages of 24-hour blood pressure monitoring as compared to spot readings taken in clinics is expected to boost adoption of ambulatory blood pressure monitors across European countries. Germany dominates the Europe ambulatory blood pressure monitors market due to rising healthcare expenditure and progressive government policies regarding prevention and treatment of hypertension.
• Asia Pacific is the fastest-growing market for cervical cancer vaccines, accounting for a share of over 22.3% in 2023. The Asia Pacific region represents a major opportunity for market players in the ambulatory blood pressure monitors market. With rising healthcare expenditures and a growing focus on preventive healthcare, the demand for blood pressure monitoring devices is increasing rapidly across several countries. China and India are expected to be the fastest growing markets due to their huge patient bases and improving access to diagnostic services. Growing awareness about hypertension and its management is further driving more patients and physicians to adopt ambulatory blood pressure monitoring.

Figure 1. Global Ambulatory Blood Pressure Monitors Market Share (%), By Region, 2023

To learn more about this report, request a free sample copy

Global Ambulatory Blood Pressure Monitors Market Drivers:

• Rising prevalence of hypertension: Rising prevalence of hypertension or high blood pressure is a major risk factor driving the growth of the global ambulatory blood pressure monitors market. For instance, according to data published by World Health Organization (WHO) in March 2023, an estimated 1.28 billion adults aged 30–79 years worldwide have hypertension, most (two-thirds) living in low- and middle-income countries
• Rising awareness about ambulatory blood pressure monitoring (ABPM) benefits: Rising awareness about the benefits of ambulatory blood pressure monitoring (ABPM) is a key factor driving the growth of the global ambulatory blood pressure monitors market. ABPM provides a more comprehensive picture of an individual's blood pressure over an extended period of time. Unlike conventional blood pressure readings taken in a clinical setting, which may be elevated due to visit-related anxiety known as white coat hypertension, ABPM enables monitoring of blood pressure during normal daily activities and periods of rest. This helps detect masked hypertension which cannot be picked up through conventional measurement methods and poses health risks. More healthcare professionals are recognizing the value of ABPM in improving cardiovascular risk-stratification and management of hypertension. Medical guidelines from bodies like the American Heart Association recommend use of ABPM for confirmation of diagnoses in certain cases.
• Growing geriatric population: Rising geriatric demographic is a key driver for growing adoption of ambulatory blood pressure monitors (ABPM). ABPM allows continuous monitoring of an individual's blood pressure over extended period outside of a clinical setting. It provides valuable insights into hypertension that may remain undetected during routine clinic visits. For example, nocturnal hypertension identified through ABPM has been associated with increased risk of cardiovascular events. ABPM helps in accurate diagnosis of various conditions like white-coat hypertension, masked hypertension, and others which commonly occur in elderly population. It also facilitates effective evaluation of antihypertensive treatment response.
• Technological advancements in BP monitoring devices: Technological advancements are significantly driving the growth of ambulatory blood pressure monitor (ABPM) market. ABPMs help improve hypertension diagnosis and management by enabling continuous monitoring of blood pressure throughout the day and night over 24-48 hour periods. Advancements like smaller, lightweight and wearable devices have made ABPM more convenient for long-term use. They can easily be worn under clothes and allow patients to go about their normal activities. This has helped increase adoption among those needing frequent monitoring.

Global Ambulatory Blood Pressure Monitors Market Opportunities

• Untapped emerging markets: Untapped emerging markets have immense potential to become a great opportunity for growth in the ambulatory blood pressure monitor market. Countries like India, Indonesia, Brazil, Mexico, and parts of Africa are experiencing rapid economic development and rise in income levels. Countries like China, India, and Brazil with huge population bases and growing middle class are witnessing growing incidences of hypertension due to genetic predisposition and changes in diet and lifestyle towards processed food, less physical activity, obesity and stress. This has created a heavy burden on public healthcare and increased demand for monitoring devices to facilitate self-care at home to reduce pressure on hospitals and clinics
• Integration of mHealth with ABPM devices: The integration of mobile health (mHealth) technologies with ambulatory blood pressure monitoring (ABPM) devices offers tremendous potential for the ABPM market in the near future. As high blood pressure has become a growing public health problem worldwide, advanced monitoring outside of clinical settings is crucial to improve management. Combining ABPM's ability to capture multi-day BP readings with mHealth's connectivity allows clinicians to remotely track patients and identify irregularities in near real-time. This helps optimize treatment regimens and lifestyle interventions.
• Product launches: Product launches by leading companies have strong potential to drive growth in the global ambulatory blood pressure monitors market. As lifestyle-related conditions like hypertension rise globally, major players are introducing next-generation monitors with advanced features. For instance, in July 2022, CardiAI Inc., a medical device research and development (R&D) organization that develops medical diagnostic devices and software, globally launched & initiated their distribution of their brand new 24-hour ambulatory blood pressure monitoring system. BPAro is a compact, portable, German-manufactured, self-monitoring blood pressure device that uses Bluetooth for wireless data collection, which is uploaded to a secure cloud database. The device provides blood pressure monitoring for evidence-based healthcare by synchronizing patient and physician, resulting in real-time, without delay. BPAro measures and automatically records patient blood pressure at regular programmed intervals

Global Ambulatory Blood Pressure Monitors Market Trends:

• Wireless connectivity in ABPM devices: The wireless connectivity in ambulatory blood pressure monitoring (ABPM) devices is having a profound impact on the market. With advancements in Bluetooth and internet of things (IoT) technology, newer ABPM devices are able to seamlessly and securely transmit a patient's blood pressure readings in real-time to their physician's clinic via a mobile application. This connectivity enables remote patient monitoring and makes the diagnostic process more convenient and efficient. Physicians can review readings almost immediately as they are measured throughout a patient's daily routine. Any aMnormal values can be identified and addressed quickly without unnecessary additional in-person visits. The wireless capabilities also allow device makers to offer software features like automated reports and data analytics tools to clinicians.
• Remote monitoring and cloudbased data analysis: The remote monitoring and cloud-based data analysis trend is having a notable impact on the ambulatory blood pressure monitor (ABPM) market. With advanced technologies allowing doctors to monitor patients' blood pressure readings remotely through wireless devices that transfer data through apps or secure web portals, it is significantly improving medical care while also driving new opportunities for ABPM manufacturers. This remote monitoring capability is enabling far more widespread use of ABPM as it removes the need for patients to schedule separate in-office visits or trips solely for the purpose of having their doctor download and analyze the blood pressure readings. With data automatically uploaded to the cloud, physicians can check on their patients' blood pressure trends remotely at any time without the patient needing to come to the office. This level of convenience is appealing both to providers and patients.
• Miniaturization of ABPM devices: Miniaturization of ambulatory blood pressure monitoring (ABPM) devices is having a significant impact on the ABPM market. With advances in microelectronics and miniaturized components, device manufacturers are able to create much smaller and lighter ABPM monitors. These new generation devices are considerably more discreet and comfortable for patients to wear. They resemble a regular watch in form factor rather than the bulky devices of the past. The reduced size has also allowed additional comfort features like water resistance and longer battery life.

Global Ambulatory Blood Pressure Monitors Market Restraints:

• High cost of ABPM devices: The high cost of ambulatory blood pressure monitoring (ABPM) devices is one of the major factors restraining the growth of the ABPM market. ABPM devices provide automatic blood pressure readings at regular intervals over a 24-hour period, thus allowing physicians to more accurately diagnose high blood pressure conditions like white-coat hypertension. However, the devices themselves come with a high price tag that makes them inaccessible for many patients. On average, a basic ABPM monitor costs around US$300-500 in the U.S. While insurance may cover part of this cost, patients pays a lump sum amount for a medical device which will be only used temporarily. This high initial investment acts as a barrier, especially for those without health insurance or with high deductible plans. As a result, many physicians are hesitant to regularly prescribe ABPM monitoring to their at-risk patients due to concerns over medical expenses.

Counterbalance: Manufactures should implement rental options for ABPM devices, thus allowing patients to use the device for a specific period without the need for a full purchase. This can be particularly beneficial for short-term monitoring needs.

• Reimbursement issues: Reimbursement issues have been a major roadblock in the widespread adoption of ambulatory blood pressure monitoring devices. The absence of consistent coverage policies across public and private payers has made these medical-grade devices unaffordable for many patients. Ambulatory blood pressure monitoring provides clinicians a more accurate view of a patient's blood pressure over a 24-hour cycle and aids early diagnosis of hypertension. However, due to lack of reimbursements, both patients and healthcare providers are hesitant to use these devices. Several medical societies and international health organizations recommend the use of ambulatory blood pressure monitoring for the diagnosis of hypertension. But reimbursement remains a challenge, especially in the U.S., Medicare in the U.S., has limited and inconsistent coverage for outpatient ambulatory blood pressure monitoring. Private insurers have also not established consistent policies for reimbursement.
• Measurement inaccuracies: Measurement inaccuracies pose one of the key challenges restraining the growth of ambulatory blood pressure monitor market. Ambulatory blood pressure monitors are worn for 24 hours or longer to measure blood pressure at regular intervals, which provides a more comprehensive view of an individual's blood pressure over extended periods of time as compared to traditional blood pressure readings taken at a clinic or office. However, inaccuracies in measurement sometimes arising due to factors like inappropriate device size and incorrect positioning can risk providing misleading results. This reduces the reliability and confidence of both patients and physicians in the readings provided by these monitors.

Figure 2. Global Ambulatory Blood Pressure Monitors Market Share (%), By Product Type, 2023

To learn more about this report, request a free sample copy

Key Developments:

Product Launches/Approval:

• In June 2022, LiveMetric, a leader in medical wearable technology, launch LiveOne, the world's first 510(k) U.S. Food and Drug Administration (FDA) cleared nano-sensor technology for monitoring blood pressure every 10 seconds. LiveOne is a wrist-worn, cuff-free solution that provides real time measurements to improve the care and treatment of people with hypertension and cardiovascular diseases. It’s innovative design provides an affordable, daily monitor which empowers users to know their blood pressure from anywhere and at any time. The band makes it possible to evaluate not only a static 24-hr ambulatory blood pressure monitoring (ABPM), but also to monitor BP over an entire week. It could also aid in the continuous research to improve diagnosis of secondary causes of hypertension that have variable BP increases.
• In May 2021, Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, launch its new wearable and continuous ambulatory blood pressure monitoring (ABPM) chest-monitoring device. As blood pressure (BP) measurement has shown to be crucial in the early detection and prevention of clinical disorders, ABPM can act as a decisive indicator of patient health, thus tracking patient cardiac data continuously in real-life settings outside of the physician's office to provide an accurate, holistic, and unbiased view of patient health.

Research and Development:

• In May 2023, Aktiia, a health tech startup transforming hypertension care, announced promising results from a preliminary study comparing their cuff-less and continual blood pressure monitor with traditional ambulatory blood pressure monitors (ABPM). The study included 52 patients enrolled in a 12-week cardiac rehabilitation program and found that the Aktiia bracelet produced daytime blood pressure measurements that were comparable to those of an ABPM.

Acquisition:

• In September 2021, SunTech Medical, Inc. a subsidiary of Halma plc., announced that it had completed the acquisition of all shares of Meditech Kft., a manufacturer of ambulatory blood pressure monitors (ABPM) and ECG Holter devices based in Budapest, Hungary. Through the acquisition, Meditech Kft., becomes a business unit of SunTech Medical, Inc., allowing SunTech Medical, Inc. to leverage the two companies' expert knowledge of blood pressure (BP) to bring better BP solutions to customers.

Top Companies in the Global Ambulatory Blood Pressure Monitors Market:

• • OSI Systems Inc.
  • SunTech Medical Inc.
  • Andon Health Co. Ltd.
  • Schiller AG
  • Omron Healthcare Co. Ltd.
  • Beurer GmBH
  • Finapres Medical Systems B.V.
  • Welch Allyn, Inc.
  • Koninklijke Philips N.V.
  • Aktiia
  • Biobeat
  • LiveMetric
  • CardiAI Inc.

Definition: Ambulatory blood pressure monitoring (ABPM) involves measuring a patient's blood pressure at regular intervals over a 24-hour period by using a portable monitor. There are two main types of ambulatory blood pressure monitors - wrist ABPM devices and arm cuff ABPM devices. Wrist ABPM devices are worn on the wrist like a watch and non-invasively measure blood pressure through the wrist. Arm cuff ABPM devices utilize a standard blood pressure cuff that is worn on the upper arm. These devices automatically inflate and measure blood pressure at preset time intervals.